{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T13:43:30Z","timestamp":1774705410211,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian Government Research Training Scheme"},{"name":"Australian Government Research Training Scheme Stipend"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.taap.2018.09.040","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T23:23:09Z","timestamp":1538090589000},"page":"78-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Validation of a clinically-relevant rodent model of statin-associated muscle symptoms for use in pharmacological studies"],"prefix":"10.1016","volume":"360","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-6347","authenticated-orcid":false,"given":"Jordon Candice","family":"Irwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew Stuart","family":"Fenning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly Rene","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca Kate","family":"Vella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"51","key":"10.1016\/j.taap.2018.09.040_bb0005","doi-asserted-by":"crossref","first-page":"39597","DOI":"10.1074\/jbc.M110.129718","article-title":"Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway","volume":"285","author":"Altun","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12917-017-0949-z","article-title":"The gastro protective effects of Cibotium Barometz hair on ethanol-induced gastric ulcer in sprague-dawley rats","volume":"13","author":"AL-Wajeeh","year":"2017","journal-title":"BMC Vet. Res."},{"issue":"6","key":"10.1016\/j.taap.2018.09.040_bb0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14740338.2015.1039980","article-title":"Statin intolerance - an attempt at a unified definition. Position paper from an international lipid expert panel","volume":"14","author":"Banach","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","article-title":"What is a relevant statin concentration in cell experiments claiming pleiotropic effects?","volume":"72","author":"Bj\u00f6rkhem-Bergman","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.taap.2018.09.040_bb0025","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","article-title":"Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a \u2018mitohormesis\u2019 mechanism involving reactive oxygen species and PGC-1","volume":"33","author":"Bouitbir","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.taap.2018.09.040_bb0030","doi-asserted-by":"crossref","unstructured":"J. Bouitbir, F. Singh, A.L. Charles, A.I. Schlagowski, A. Bonifacio, A. Echaniz-Laguna, B. Geny, S. Krahenbuhl, J. Zoll, Statins trigger mitochondrial reactive oxygen species-induced apoptosis in glycolytic skeletal muscle, Antioxid. Redox Signal.24(2) (2016) 84\u201398.","DOI":"10.1089\/ars.2014.6190"},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1123\/japa.15.3.336","article-title":"Effects of aging on type II muscle fibers: a systematic review of the literature","volume":"15","author":"Brunner","year":"2007","journal-title":"J. Aging Phys. Act."},{"key":"10.1016\/j.taap.2018.09.040_bb0040","unstructured":"C. Buettner, S.H. Lecker, Molecular basis for statin-induced muscle toxicity: implications and possibilities, Pharmacogenomics9(8) (2008) 1133\u20131142."},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.880020308","article-title":"Morphology and physiology of skeletal muscle in aging rodents","volume":"2","author":"Caccia","year":"1979","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.taap.2018.09.040_bb0050","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bcp.2011.01.022","article-title":"Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle","volume":"81","author":"Camerino","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.taap.2018.09.040_bb0055","doi-asserted-by":"crossref","first-page":"e12345","DOI":"10.1371\/journal.pone.0012345","article-title":"Age- and gender-related changes in contractile properties of non-atrophied edl muscle","volume":"5","author":"Chan","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.taap.2018.09.040_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168065","article-title":"The impact of exercise on statin-associated skeletal muscle myopathy","volume":"11","author":"Chung","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/mus.23465","article-title":"Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice","volume":"47","author":"D'Antona","year":"2013","journal-title":"Muscle Nerve"},{"issue":"1, Supplement 2","key":"10.1016\/j.taap.2018.09.040_bb0070","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/0002-9343(91)90053-Z","article-title":"Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin","volume":"91","author":"Dujovne","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.taap.2018.09.040_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tox.2016.06.015","article-title":"Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model","volume":"359\u2013360","author":"El-Ganainy","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2018.09.040_bb0080","article-title":"Comparative study of the myopathic effects of atorvastatin and rosuvastatin in rats","volume":"265","author":"El-Ganainy","year":"2016","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0085","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5114\/aoms.2016.59938","article-title":"Molecular mechanisms of statin intolerance","volume":"12","author":"Gluba-Brzozka","year":"2016","journal-title":"Arch. Med. Sci."},{"issue":"5","key":"10.1016\/j.taap.2018.09.040_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128398","article-title":"Statin-induced increases in atrophy gene expression occur independently of changes in PGC1alpha protein and mitochondrial content","volume":"10","author":"Goodman","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.taap.2018.09.040_bb0095","doi-asserted-by":"crossref","first-page":"e51537","DOI":"10.1371\/journal.pone.0051537","article-title":"Acute toxicity and gastroprotection studies of a new schiff base derived copper (II) complex against ethanol-induced acute gastric lesions in rats","volume":"7","author":"Hajrezaie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.09.040_bb0100","doi-asserted-by":"crossref","unstructured":"J-I. Hanai, P. Cao, P. Tanksale, S. Imamura, E. Koshimizu, J. Zhao, S. Kishi, M. Yamashita, P.S. Phillips, V.P. Sukhatme, S.H. Lecker, The muscle-specific ubiquitin ligase atrogin-1\/mafbx mediates statin-induced muscle toxicity, J. Clin. Invest.117(12) (2007) 3940\u201351.","DOI":"10.1172\/JCI32741"},{"issue":"12","key":"10.1016\/j.taap.2018.09.040_bb0105","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCULATIONAHA.117.027067","article-title":"Evaluating the impact and cost-effectiveness of statin use guidelines for primary prevention of coronary heart disease and stroke","volume":"136","author":"Heller","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mus.22081","article-title":"Transcriptional deficits in oxidative phosphorylation with statin myopathy","volume":"44","author":"Hubal","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.taap.2018.09.040_bb0115","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.phrs.2017.09.013","article-title":"The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: a systematic review and meta-analysis","volume":"128","author":"Irwin","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.taap.2018.09.040_bb0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/1074248414529622","article-title":"Addressing statin adverse effects in the clinic: The 5 Ms","volume":"19","author":"Katz","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.09.040_bb0125","unstructured":"E. Keltz, F.Y. Khan, G. Mann, Rhabdomyolysis. The role of diagnostic and prognostic factors, Muscles Ligament Tendons J. 3(4) (2013) 303\u2013312."},{"key":"10.1016\/j.taap.2018.09.040_bb0130","doi-asserted-by":"crossref","unstructured":"A. Khan, K.C. Maki, M.K. Ito, J.D. Cohen, C.A. Sponseller, M. Bell, E.A. Brinton, T.A. Jacobson, Statin associated muscle symptoms: characteristics of patients and recommendations by providers, J. Clin. Lipidol. 9(3) (2015) 460.","DOI":"10.1016\/j.jacl.2015.03.080"},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.freeradbiomed.2011.10.449","article-title":"Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes","volume":"52","author":"Kwak","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.taap.2018.09.040_bb0140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0002-9149(97)89180-1","article-title":"The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle","volume":"77","author":"Laaksonen","year":"1996","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.taap.2018.09.040_bb0145","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme Q10 level in statin-related myopathy","volume":"62","author":"Lamperti","year":"2005","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","article-title":"Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance","volume":"61","author":"Larsen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.taap.2018.09.040_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.fjc.0000210072.48991.f6","article-title":"Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats","volume":"47","author":"Loch","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2018.09.040_bb0165","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.41.7.1159","article-title":"Cholesterol-lowering agent myopathy (CLAM)","volume":"41","author":"London","year":"1991","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1113\/jphysiol.2008.164699","article-title":"Blunted Akt\/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy","volume":"587","author":"Mallinson","year":"2009","journal-title":"J. Physiol."},{"issue":"24","key":"10.1016\/j.taap.2018.09.040_bb0175","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1113\/jphysiol.2012.238022","article-title":"Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents","volume":"590","author":"Mallinson","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.taap.2018.09.040_bb0180","doi-asserted-by":"crossref","unstructured":"J.E. Mallinson, K. Marimuthu, A. Murton, A. Selby, K. Smith, D. Constantin-Teodosiu, M.J. Rennie, P.L. Greenhaff, Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mrna expression, J. Physiol. 593(5) (2015) 1239\u20131257.","DOI":"10.1113\/jphysiol.2014.285577"},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11883-012-0291-7","article-title":"How DO we improve patient compliance and adherence to long-term statin therapy?","volume":"15","author":"Maningat","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1378\/chest.123.3.875","article-title":"Effects of chronic intermittent asphyxia on rat diaphragm and limb muscle contractility","volume":"123","author":"McGuire","year":"2003","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.taap.2018.09.040_bb0195","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/mus.22236","article-title":"Statin-associated changes in skeletal muscle function and stress response after novel or accustomed exercise","volume":"44","author":"Meador","year":"2011","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.taap.2018.09.040_bb0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5535\/arm.2015.39.2.155","article-title":"Aging of Skeletal Muscle Fibers","volume":"39","author":"Miljkovic","year":"2015","journal-title":"Ann. Rehabil. Med."},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0205","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bcp.12360","article-title":"Mechanisms and assessment of statin-related muscular adverse effects","volume":"78","author":"Mo\u00dfhammer","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2018.09.040_bb0210","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1152\/jn.00687.2010","article-title":"Changes of the force-frequency relationship in the rat medial gastrocnemius muscle after total transection and hemisection of the spinal cord","volume":"105","author":"Mrowczynski","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.taap.2018.09.040_bb0215","unstructured":"D.M. Muntean, P.D. Thompson, A.L. Catapano, M. Stasiolek, J. Fabis, P. Muntner, M.-C. Serban, M. Banach, Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?, Drug Discov. Today22(1) (2017) 85\u201396."},{"key":"10.1016\/j.taap.2018.09.040_bb0220","doi-asserted-by":"crossref","unstructured":"A. Muraki, K. Miyashita, M. Mitsuishi, M. Tamaki, K. Tanaka, H. Itoh, Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance, J. Appl. Physiol. 113(3) (2012) 479\u2013486.","DOI":"10.1152\/japplphysiol.01362.2011"},{"key":"10.1016\/j.taap.2018.09.040_bb0225","doi-asserted-by":"crossref","unstructured":"H. Naba, C. Kuwayama, C. Kakinuma, S. Ohnishi, T. Ogihara, Eisai hyperbilirubinemic rat (EHBR) as an animal model affording high drug-exposure in toxicity studies on organic anions, Drug Metabol. Pharmacokinet. 19(5) (2004) 339\u2013351.","DOI":"10.2133\/dmpk.19.339"},{"issue":"4","key":"10.1016\/j.taap.2018.09.040_bb0230","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2131\/jts.36.445","article-title":"Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats","volume":"3","author":"Obayashi","year":"2011","journal-title":"J. Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"Paiva","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.09.040_bb0240","unstructured":"B.A. Parker, P.D. Thompson, Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes, Exerc. Sport Sci. Rev. 40(4) (2012) 188\u2013194."},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0250","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/cc13897","article-title":"Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review","volume":"18","author":"Petejova","year":"2014","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/clp.09.83","article-title":"Survey of muscle characteristics after statin-induced rhabdomyolysis","volume":"5","author":"Phillips","year":"2010","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.taap.2018.09.040_bb0260","doi-asserted-by":"crossref","unstructured":"S. Pierno, A. De Luca, A. Liantonio, C. Camerino, D. Conte Camerino, Effects of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle, Eur. J. Pharmacol. 364(1) (1999) 43\u201348.","DOI":"10.1016\/S0014-2999(98)00817-6"},{"key":"10.1016\/j.taap.2018.09.040_bb0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12891-016-1306-2","article-title":"A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles","volume":"17","author":"Piette","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm85030029","article-title":"Evaluation of acute and subacute oral toxicity induced by ethanolic extract of marsdenia tenacissima leaves in experimental rats","volume":"85","author":"Porwal","year":"2017","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.taap.2018.09.040_bb0275","unstructured":"S.K. Powers, L.L. Ji, A.N. Kavazis, M.J. Jackson, Reactive oxygen species: impact on skeletal muscle, Compr. Physiol.1(2) (2011) 941\u2013969."},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0009-9120(96)00003-6","article-title":"A simplified method for the analysis of hydroxyproline in biological tissues","volume":"29","author":"Reddy","year":"1996","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.taap.2018.09.040_bb0285","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1203\/00006450-199606000-00016","article-title":"Differential effects of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors on the development of myopathy in young rats","volume":"39","author":"Reijneveld","year":"1996","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0290","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"An assessment by the Statin Muscle Safety Task Force: 2014 update","volume":"8","author":"Rosenson","year":"2014","journal-title":"J. Clin. Lipidol."},{"issue":"10","key":"10.1016\/j.taap.2018.09.040_bb0295","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2017.07.752","article-title":"Optimizing cholesterol treatment in patients with muscle complaints","volume":"70","author":"Rosenson","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.taap.2018.09.040_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157431","article-title":"The gastroprotective effect of vitex pubescens leaf extract against ethanol-provoked gastric mucosal damage in sprague-dawley rats","volume":"11","author":"Saeed Al-Wajeeh","year":"2016","journal-title":"PLoS One"},{"issue":"2006","key":"10.1016\/j.taap.2018.09.040_bb0305","first-page":"2006","article-title":"Purification of nucleic acids by extraction with phenol:chlorofom","volume":"1","author":"Sambrook","year":"2006","journal-title":"CSH Protoc."},{"key":"10.1016\/j.taap.2018.09.040_bb0310","doi-asserted-by":"crossref","first-page":"a2286","DOI":"10.1136\/bmj.a2286","article-title":"Statin induced myopathy","volume":"337","author":"Sathasivam","year":"2008","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2003.08.013","article-title":"Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats","volume":"194","author":"Schaefer","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.09.040_bb0320","doi-asserted-by":"crossref","unstructured":"J.L. Seachrist, C.-M. Loi, M.G. Evans, K.A. Criswell, C.E. Rothwell, Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity, Toxicol. Sci.88(2) (2005) 551\u2013561.","DOI":"10.1093\/toxsci\/kfi305"},{"issue":"4","key":"10.1016\/j.taap.2018.09.040_bb0325","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/01.CIR.85.4.1293","article-title":"Expanded clinical evaluation of lovastatin (EXCEL) study results. effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins","volume":"85","author":"Shear","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2018.09.040_bb0330","unstructured":"J. Sidaway, Y. Wang, A.M. Marsden, T.C. Orton, F.R. Westwood, C.T. Azuma, R.C. Scott, Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy, Xenobiotica39(1) (2009) 90\u201398."},{"issue":"1","key":"10.1016\/j.taap.2018.09.040_bb0335","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbagen.2013.09.010","article-title":"Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles","volume":"1840","author":"Simsek Ozek","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.taap.2018.09.040_bb0340","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0022-3565(25)24759-0","article-title":"HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine a interaction and mechanism studies","volume":"257","author":"Smith","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.taap.2018.09.040_bb0345","first-page":"356","article-title":"Impact of oxidative stress on exercising skeletal muscle","volume":"5","author":"Steinbacher","year":"2015","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.taap.2018.09.040_bb0350","doi-asserted-by":"crossref","unstructured":"J. Sugatani, S. Sadamitsu, M. Kurosawa, S. Ikushiro, T. Sakaki, A. Ikari, M. Miwa, Nutritional status affects fluvastatin-induced hepatotoxicity and myopathy in rats, Drug Metab. Dispos. 38(10) (2010) 1655\u20131664.","DOI":"10.1124\/dmd.110.034090"},{"key":"10.1016\/j.taap.2018.09.040_bb0355","unstructured":"D.A. Taha, C.H. De Moor, D.A. Barrett, J.B. Lee, R.D. Gandhi, C.W. Hoo, P. Gershkovich, The role of acid-base imbalance in statin-induced myotoxicity, Transl. Res. 174(2016) 140\u2013160."},{"issue":"20","key":"10.1016\/j.taap.2018.09.040_bb0360","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.taap.2018.09.040_bb0365","doi-asserted-by":"crossref","unstructured":"P.P. Toth, A.M. Patti, R.V. Giglio, D. Nikolic, G. Castellino, M. Rizzo, M. Banach, Management of statin intolerance in 2018: still more questions than answers, Am. J. Cardiovasc. Drugs18(3) (2018) 157\u2013173.","DOI":"10.1007\/s40256-017-0259-7"},{"issue":"11","key":"10.1016\/j.taap.2018.09.040_bb0370","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1096\/fj.11-184218","article-title":"Effects of myosin heavy chain (MHC) plasticity induced by hmgcoa-reductase inhibition on skeletal muscle functions","volume":"25","author":"Trapani","year":"2011","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.taap.2018.09.040_bb0375","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1185\/03007990802469102","article-title":"Statin discontinuation: an underestimated risk?","volume":"24","author":"Tziomalos","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.taap.2018.09.040_bb0380","unstructured":"F.R. Westwood, A. Bigley, K. Randall, A.M. Marsden, R.C. Scott, Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity, Toxicol. Pathol. 33(2) (2005) 246\u2013257."},{"issue":"2","key":"10.1016\/j.taap.2018.09.040_bb0385","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0192623307311412","article-title":"Rosuvastatin: characterization of induced myopathy in the rat","volume":"36","author":"Westwood","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2018.09.040_bb0390","doi-asserted-by":"crossref","unstructured":"N.P. Whitehead, M.J. Kim, K.L. Bible, M.E. Adams, S.C. Froehner, A New Therapeutic Effect of simvastatin revealed by functional improvement in muscular dystrophy, Proc. Natl. Acad. Sci. USA 112(41) (2015) 12864\u201312869.","DOI":"10.1073\/pnas.1509536112"},{"issue":"12","key":"10.1016\/j.taap.2018.09.040_bb0395","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/jcmm.12438","article-title":"Compensatory renal hypertrophy following uninephrectomy is calcineurin-independent","volume":"18","author":"Williams","year":"2014","journal-title":"J. Cell. Mol. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18304460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18304460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T20:35:49Z","timestamp":1755722149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18304460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":79,"alternative-id":["S0041008X18304460"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.09.040","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a clinically-relevant rodent model of statin-associated muscle symptoms for use in pharmacological studies","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}